Bio-hybrid material, production method therefor, and stent
Provided is a bio-hybrid material that does not cause elution of nickel ions and has an excellent endothelialization ability, a production method therefor, and a stent. The bio-hybrid material ( 101 ) used includes an alloy part ( 11 ) free of Ni, an organic acid ( 12 ) having two or more active esters, and a cytokine ( 13 ). The alloy part ( 11 ) free of Ni forms an ester bond with the organic acid ( 12 ), and the organic acid ( 12 ) and the cytokine ( 13 ) are immobilized via an amide bond.
1. A bio-hybrid material comprising:
an alloy part free of Ni;
an organic acid having three or more active ester groups; and
a cytokine,
wherein the alloy part free of Ni forms an ester bond with the organic acid through one of the three or more active ester groups of the organic acid, and the organic acid and the cytokine are immobilized via an amide bond through active ester groups free of the ester bond with the alloy part free of Ni among the three or more active ester groups of the organic acid.
2. The bio-hybrid material according to claim 1 , wherein the cytokine is one selected from a group consisting of Vascular Endothelial Growth Factor (VEGF), Epithelial Growth Factor (EGF), Fibroblast Growth Factor (FGF), Hepatocyte Growth Factor (HGF), Platelet-Derived Growth Factor (PDGF), and Bone Morphogenetic Protein (BMP).
3. The bio-hybrid material according to claim 1 , wherein the organic acid having three or more active ester groups is one selected from a group consisting of citric acid, oxalacetic acid, cis-aconitic acid, 2-ketoglutaric acid, and any derivative thereof.
4. The bio-hybrid material according to claim 1 , wherein the alloy part free of Ni is an alloy containing two or more elements selected from a group consisting of Fe, Mo, Co, and Cr.
5. The bio-hybrid material according to claim 4 , wherein the alloy contains nitrogen in an amount ranging from 0.5 wt % to 1 wt %.
6. The bio-hybrid material according to claim 2 , wherein the organic acid having three or more active ester groups is one selected from a group consisting of citric acid, oxalacetic acid, cis-aconitic acid, 2-ketoglutaric acid, and any derivative thereof.
7. The bio-hybrid material according to claim 2 , wherein the alloy part free of Ni is an alloy containing two or more elements selected from a group consisting of Fe, Mo, Co, and Cr.
8. The bio-hybrid material according to claim 3 , wherein the alloy part free of Ni is an alloy containing two or more elements selected from a group consisting of Fe, Mo, Co, and Cr.
9. The bio-hybrid material according to claim 6 , wherein the alloy part free of Ni is an alloy containing two or more elements selected from a group consisting of Fe, Mo, Co, and Cr.
10. The bio-hybrid material according to claim 7 , wherein the alloy contains nitrogen in an amount ranging from 0.5 wt % to 1 wt %.
11. The bio-hybrid material according to claim 8 , wherein the alloy contains nitrogen in an amount ranging from 0.5 wt % to 1 wt %.
12. The bio-hybrid material according to claim 9 , wherein the alloy contains nitrogen in an amount ranging from 0.5 wt % to 1 wt %.
13. The bio-hybrid material according to claim 1 , wherein the alloy part free of Ni as an alloy containing an element selected from a group consisting of Ti, B, and Nb.
14. The bio-hybrid material according to claim 4 , wherein the alloy part free of Ni as an alloy containing an element selected from a group consisting of Ti, B, and Nb.
15. The bio-hybrid material according to claim 5 , wherein the alloy part free of Ni as an alloy containing an element selected from a group consisting of Ti, B, and Nb.
16. A stent comprising the bio-hybrid material according to claim 1 .
17. A stent comprising the bio-hybrid material according to claim 2 .
18. A bio-hybrid material comprising:
an alloy part free of Ni having a hydroxyl group on a surface;
an organic acid having three or more active ester groups; and
a cytokine,
wherein the alloy part free of Ni forms an ester bond with the organic acid through one of the three or more active ester groups of the organic acid, and the organic acid and the cytokine are immobilized via an amide bond through active ester groups free of the ester bond with the ally part free of Ni among the three or more active ester groups of the organic acid.
19. A bio-hybrid material comprising:
an alloy part free of Ni having a hydroxyl group on a surface;
an organic acid having three or more succinimidyl ester groups; and
a cytokine,
wherein the alloy part free of Ni forms an ester bond with the organic acid through one of the three or more active ester groups of the organic acid, and the organic acid and the cytokine are immobilized via an amide bond through active ester groups free of the ester bond with the ally part free of Ni among the three or more active ester groups of the organic acid.